long term – Parents Of Allergic Children http://parentsofallergicchildren.org/ Wed, 13 Apr 2022 11:46:39 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://parentsofallergicchildren.org/wp-content/uploads/2021/06/icon-5.png long term – Parents Of Allergic Children http://parentsofallergicchildren.org/ 32 32 Protein in tick saliva emerges as possible treatment for chronic pain and severe itching https://parentsofallergicchildren.org/protein-in-tick-saliva-emerges-as-possible-treatment-for-chronic-pain-and-severe-itching/ Sat, 19 Mar 2022 19:17:23 +0000 https://parentsofallergicchildren.org/protein-in-tick-saliva-emerges-as-possible-treatment-for-chronic-pain-and-severe-itching/ DURHAM, England — Ticks are one of the most feared insects in humans, but they can bring good after all. A new drug derived from the saliva of pathogenic arachnids could potentially relieve itching and chronic pain in humans. The protein was discovered in the saliva of the brown ear tick, which spreads the parasites […]]]>

DURHAM, England — Ticks are one of the most feared insects in humans, but they can bring good after all. A new drug derived from the saliva of pathogenic arachnids could potentially relieve itching and chronic pain in humans.

The protein was discovered in the saliva of the brown ear tick, which spreads the parasites that cause East Coast fever in cattle across Africa. Today, it is hoped that drugs made from this drug will one day replace opioids, which can be ineffective, have serious side effects, and be addictive.

Researchers from the universities of Durham and Newcastle in England claim that the protein, called Votucalis, was able to relieve both pain and itching in a study involving mice. The compound was discovered when researchers found that the brown ear tick was able to secrete it into its host. They say Votucalis was delivered to the host while they were feeding, so the host didn’t know they had been bitten.

On a chemical level, the protein binds to histamine produced in the body from activation, which reduces responses to itchiness or chronic pain. Unlike opioids, research shows that votucalis does not enter the brain, which means it is much less likely to be addictive and less likely to cause side effects.

“Votucalis has already been tested in humans with other conditions, including conjunctivitis, with no major side effects, so the potential for it to be developed into a drug to combat chronic pain and itching is definitely there. “said co-author Dr. Ilona Obara, of Newcastle University, in a statement. “It is amazing that a protein in the saliva of this tiny creature can prevent chronic pain and itching in humans. These are conditions that bring an enormous amount of misery, and current drugs show limited efficacy, and can also often be detrimental to patients.

Possible treatments for the drug include atopic dermatitis, psoriasis, arthritis, diabetes, sciatica, and back injuries.

The researchers say the next step toward clinical testing is to develop a delivery system to effectively deliver the drug to the site of itching and pain. “Persistent or chronic pain is a huge global health challenge, affecting more than 20% of the population,” says co-author Dr Paul Chazot of Durham University. “It is the number one reason Britons see their doctor and it is recognized as a priority disease by the World Health Organization.

“The National Institute for Health and Care Excellence (NICE) has recommended that current opioid and gabapentinoid pain relievers should not be prescribed to patients newly diagnosed with chronic pain, except for people with cancer, so there is an urgent need to develop a new long-term treatment – a long-lasting, effective and safe-to-use drug,” continues Chazot. “Our study is the first to show evidence of the itch and pain-relieving potential of Votucalis, which is very exciting. We may be on the verge of discovering a viable alternative to opioid and gabapentinoid drugs.

The research is published in the journal Frontiers in Pharmacology.

South West News Service writer Joe Morgan contributed to this report.

]]>
HEALTH MATTERS 3/11: Take action to prevent asthma flare-ups in children https://parentsofallergicchildren.org/health-matters-3-11-take-action-to-prevent-asthma-flare-ups-in-children/ Tue, 08 Mar 2022 22:04:40 +0000 https://parentsofallergicchildren.org/health-matters-3-11-take-action-to-prevent-asthma-flare-ups-in-children/ By Julie A. Caucino, DO Does your child complain of not being able to catch their breath when they leave the football or basketball field? Do they wheeze after playing with the family pet? Do they constantly cough after being outside in the cold? These are signs that could indicate that your child is one […]]]>

By Julie A. Caucino, DO

Does your child complain of not being able to catch their breath when they leave the football or basketball field?

Do they wheeze after playing with the family pet?

Do they constantly cough after being outside in the cold?

These are signs that could indicate that your child is one of the millions of people in the United States who suffer from asthma, a chronic respiratory disease that can make it difficult for children to breathe.

If you suspect your child has asthma, see your pediatrician or allergy and asthma specialist for assessment, treatment, and to create an asthma action plan to prevent and manage flare-ups .

Common in childhood

Asthma is inflammation and narrowing of the airways, often producing excess mucus that makes it difficult to breathe.

Asthma is common in childhood, according to the American Academy of Pediatrics, which estimates that 10% to 15% of elementary school children in the United States have or have had the disease.

Although it is not known why some children develop asthma, studies have identified some predictors of the condition, including:

• Inhalant, food and skin allergies such as eczema.
• Family history of allergies or asthma.
• Prenatal or postnatal exposure to cigarette smoke.
• Live in an area with high air pollution.
• Possible obesity.

Wheezing isn’t the only symptom

Although wheezing is often associated with asthma, you don’t have to be wheezing to have asthma. Other signs and symptoms, which may occur intermittently, may include:

• A persistent cough that gets worse with the cold or lasts longer than normal after cold symptoms have disappeared.
• Cough or shortness of breath causing the child to wake up during sleep or early in the morning.
• Rapid breathing.
• Shortness of breath and/or chest tightness during exercise.
• Not wanting to participate in sports, dancing or other physical activities.
• Younger children may complain that their chests are “sore” or that they feel “funny”.
• The feeling of not being able to breathe deeply.
• Tired.

According to the American Academy of Allergy, Asthma and Immunology, asthma flare-ups are most often triggered by allergens and colds. Common allergens include:

• Dust and mites
• Pollen
• Pet dander
• Molds
• Cockroaches and rodents

Non-allergic triggers such as cold air, second-hand smoke, temperature changes, exercise, and air pollution can also trigger asthma symptoms.

Diagnosis and treatment

When diagnosing asthma, a detailed history is essential. Asthma in children can sometimes be difficult to diagnose, especially at a younger age. Your doctor may ask you to describe the symptoms and when and where they occur.

Do you notice any patterns? For example, do the symptoms reappear after visiting a friend’s house where there is a dog or cat? Do they happen almost every time the child has a cold? Or do they happen after running outside?

Identifying what triggers the symptoms is one of the most important steps towards an accurate diagnosis and treatment plan.

Additionally, allergy testing or, depending on your child’s age, a lung function test may be recommended to manage your child’s asthma.

Asthma treatment involves medication, education, and environmental control. Asthma medications typically focus on long-term management to control the disease and prevent flare-ups, as well as rapid-relief treatment to quickly reduce symptoms when they occur.

Controller medications, most often low-dose inhaled steroids, are usually used daily to stop asthma flare-ups before they happen. The National Institutes of Health’s Asthma Management Guidelines for Children recommend that children who have symptoms more than twice a week or who wake up more than twice a month because of their symptoms use controller medications .

Controller medications may also be recommended at certain times of the year or in certain situations known to trigger your child’s asthma symptoms, such as during spring allergy season or when your child catches a cold.

Quick-relief medications, such as albuterol, are taken for short-term relief and work quickly to open the airways and restore normal breathing.

Asthma Action Plan

If your child is diagnosed with asthma, it’s important to work with your doctor to develop a written asthma action plan to help manage the condition. In general, the plan should include:

• Treatment information, such as what drugs to take and when.
• A list of possible triggers.
• Early symptoms and how to treat them.
• How to initially manage an asthma attack.
• When to call the doctor or go to the emergency room.

The American Academy of Pediatrics and the American Academy of Allergy Asthma and Immunology note that everyone who cares for your child should have a copy of their asthma action plan.

In most cases, you can manage your child’s asthma at home in consultation with your doctor. However, if your child’s symptoms are severe or worsening, or if the medications do not work, seek emergency care immediately.

Although childhood asthma can be a serious condition, by identifying the triggers, seeking treatment, and taking action, you and your child will be able to breathe easier.

To find a physician affiliated with Penn Medicine Princeton Health, call 888-742-7496 or visit www.princetonhcs.org.

Julie A. Caucino, DO, is board certified in Allergy and Immunology and is on the medical staff at Penn Medicine Princeton Health.

]]>
Combustion fireplaces: what you need to know https://parentsofallergicchildren.org/combustion-fireplaces-what-you-need-to-know/ Sat, 05 Mar 2022 00:54:58 +0000 https://parentsofallergicchildren.org/combustion-fireplaces-what-you-need-to-know/ What is a burn? Burn pits are a common method of waste disposal primarily used by the United States military outside the United States. Basically, it is an open pit area used to burn solid waste on a large scale. The types of waste burned can range from chemicals and human waste to food scraps […]]]>

What is a burn?

Burn pits are a common method of waste disposal primarily used by the United States military outside the United States. Basically, it is an open pit area used to burn solid waste on a large scale. The types of waste burned can range from chemicals and human waste to food scraps and rubber, among others.

Smoke and fumes from pits can be toxic. Exposure to pits can cause short and long term health problems. It can be worse if you have pre-existing breathing problems like asthma or other lung and heart conditions.

The Department of Veterans Affairs (VA) estimates that approximately 3.5 million US military personnel may have been exposed to burning fireplaces.

Where are combustion pits used?

The U.S. military typically creates fire pits at bases outside of the United States, such as the Middle East, Africa, and parts of Asia. Locations include:

  • Iraq
  • Afghanistan
  • Kuwait
  • Saudi Arabia
  • Bahrain
  • Djibouti
  • Oman
  • Qatar
  • United Arab Emirates
  • Uzbekistan
  • Syria

Burn pits are also created on large bodies of water. This includes the Persian Gulf, Gulf of Oman, Gulf of Aden, Arabian Sea, and Red Sea.

What things are burned in the burn pits?

Burn pits are primarily used to dispose of solid waste. This may include:

  • Chemical products
  • To paint
  • medical waste
  • human waste
  • food waste
  • Metals like aluminum
  • Cans
  • Unexploded ordnance
  • Oil
  • Lubricant products
  • Plastics
  • polystyrene
  • Rubber
  • Wood

Combustion sources and health effects

Burning large amounts of waste in the open can produce far more toxic fumes than confined burning in an incinerator. The smoke can cause both short-term irritation and long-term health issues.

Short-term health problems are usually temporary and tend to go away when exposure stops. Symptoms you may have are:

  • Red and irritated eyes
  • To cough
  • burning throat
  • Itchy skin
  • Rashes
  • Difficulty breathing

Some people exposed to combustion fireplaces can develop long-term health problems. Exposure can also aggravate certain pre-existing conditions such as asthma, allergies, rhinitis and sinusitis.

Veterans have reported several long-term issues that affect:

  • The skin
  • The eyes
  • Kidney
  • Liver
  • reproductive system
  • Central nervous system
  • Heart
  • Peripheral nervous system
  • Digestive tract
  • Lungs

Some service members have also reported certain types of cancer among other illnesses.

Currently, there is not enough research and medical evidence to directly link burning fireplaces to long-term health issues, including cancer. But certain risk factors can increase your likelihood of developing short- or long-term problems.

They understand:

  • Types of waste burned in the pit
  • Distance, duration and frequency of exposure to the burn pit
  • Weather and wind direction
  • Other dangerous elements in the air

Fire pits are also bad for the environment. In addition to US military personnel, pollutants from the burning pits also pose a health risk to residents of the area. They cannot leave as easily as the troops and suffer the consequences.

Combustion pit register

To study the health risks of exposure to burning pits, the VA set up a registry called the Airborne Hazards and Open Burn Pit Registry (AHOBPR) in 2014. The registry is designed to help researchers collect data and to better understand the potential health effects of combustion fireplaces.

You can participate in the registry if you were on active military duty in:

  • Specified regions of the Middle East and Southwest Asia with hotspots after August 2, 1990
  • Afghanistan or Djibouti on or after September 11, 2001

You are eligible to participate even if you don’t have a medical condition or don’t remember being exposed to toxins from the fireplaces. Participation is voluntary and you will be required to complete and submit a questionnaire.

Can you get VA disability for exposure to the burn pit?

The VA recognizes that exposure to the burn pit can cause serious health problems. If you have been exposed to toxins from combustion fireplaces, you can file a claim for compensation and benefits.

To be entitled to benefits, there is no need for a burden of proof if you have:

  • One of 27 possible conditions caused by exposure to toxins. This includes asthma, rhinitis, sleep apnea, certain cancers and other lung problems.
  • Developed any of the listed conditions within 10 years of leaving active military service.

If you are unsure of your eligibility, speak to your VA health care provider.

What about backyard fire pits?

Burning trash in your backyard is not similar to military grade burn pits. It is also different from recreational fireplaces and campfires. Depending on the state or city you live in, it may be illegal to burn some or all types of trash. This includes waste such as paper, plastics, wood scraps or food scraps that would otherwise need to be recycled or landfilled. If you are caught using burning barrels or open fires to dispose of trash, you could be fined for the violation.

Fireplaces can release dangerous chemicals called dioxins directly into the atmosphere. They can affect air quality and enter water supplies. Dioxins are harsh chemicals that can cause serious health problems, even in small amounts, such as heart, lung, skin and developmental problems, and even cancer. Toxins can affect loved ones, neighbors and the community as a whole.

Military burners: what do we do about them?

Since 2010, the government has taken steps to protect US service members and reduce serious side effects from smoke from burning fireplaces. This includes some policy changes to better manage hot spots and limit exposure.

New firebox requirements include:

  • Create hotspots in downwind locations away from military living areas and where civilians live
  • Limit the size of the combustion chambers
  • Regulate waste that goes into burn pits
  • Specification of burn times — 3 hours after sunrise and 3 hours before sunset

Further research needs to be conducted to find alternative strategies to fireplaces to minimize financial and health burdens for all involved.

If you are concerned about exposure to the burn site and symptoms, talk to your doctor. VA Health Care provides free medical services to combat veterans for up to 5 years after active duty.

]]>
Oversight board opposes bill to end personal belief exemption for COVID vaccines https://parentsofallergicchildren.org/oversight-board-opposes-bill-to-end-personal-belief-exemption-for-covid-vaccines/ Fri, 04 Mar 2022 00:53:44 +0000 https://parentsofallergicchildren.org/oversight-board-opposes-bill-to-end-personal-belief-exemption-for-covid-vaccines/ The bill was introduced Jan. 24 by Sen. Richard Pan (D-Sacramento). It builds on an existing bill, SB 277, which passed in 2015 and ended the personal belief exemption for all vaccines currently required for children to attend school. Governor Gavin Newsom has previously said he plans to make vaccines mandatory when they are fully […]]]>

The bill was introduced Jan. 24 by Sen. Richard Pan (D-Sacramento). It builds on an existing bill, SB 277, which passed in 2015 and ended the personal belief exemption for all vaccines currently required for children to attend school.

Governor Gavin Newsom has previously said he plans to make vaccines mandatory when they are fully approved by the US Food and Drug Administration. However, he had indicated that he would go on a personal belief exemption, which SB 871 would remove.

SB 871 is still going through multiple committee reviews before it reaches the Assembly and Senate floors, let alone the Governor’s office for approval. The letter says long-term data on the vaccine’s effect on children are lacking and the risks are unknown. But the letter also lends the council’s thoughts on the mandates of local school districts.

“School districts already have a heavy burden associated with the changes and loss of staff due to the pandemic,” the letter read. “Putting another state-mandated local program in the districts would be devastating.”

Community members also spoke at the meeting in support of the letter, including the president of the local anti-vaccine group Unmask Tulare County, Jimmy Malloy.

“This is obviously another piece of legislation that is just bad business,” Malloy said in a public comment. “If we really want something done about this, it will take hundreds of thousands of people to reach out to their members of Congress and really stink.”

]]>
New AAAAI President Highlights Meeting Highlights and Term Priorities https://parentsofallergicchildren.org/new-aaaai-president-highlights-meeting-highlights-and-term-priorities/ Mon, 21 Feb 2022 14:07:54 +0000 https://parentsofallergicchildren.org/new-aaaai-president-highlights-meeting-highlights-and-term-priorities/ February 21, 2022 5 minute read ADD A SUBJECT TO EMAIL ALERTS Receive an email when new articles are published on Please provide your email address to receive an email when new articles are published on . ” data-action=”subscribe”> Subscribe We have not been able to process your request. Please try […]]]>

February 21, 2022

5 minute read


We have not been able to process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

David A. Khan, MD, FAAAAI, of University of Texas Southwestern Medical Center, will be installed as president of the American Academy of Allergy, Asthma & Immunology at its annual meeting Feb. 25-28 in Phoenix.

According to Khan, this year’s conference will unveil innovative research and launch new programs and opportunities for AAAAI and its members.

What’s going on in Phoenix

The meeting will begin under the theme “Asthma difficult to control”, which will be the subject of 20% of the more than 225 scheduled sessions.

“It’s an important topic because it’s an area that’s really seen an explosion of different therapies to manage these very difficult patients,” Khan told Healio.

David A. Khan

“It’s great that we now have more treatment options for these patients, but education is an area of ​​great need,” he continued. “We have assessed that our members are genuinely interested in learning more about this topic, and we are happy to provide information.”

COVID-19, which continues to dominate the headlines, is another hot topic based on the multiple abstracts and original studies that will be featured.

“As allergists, one of the things that we have faced and have faced is patients who have had immediate reactions to COVID-19 vaccinations and who have tried to figure out how we can get them vaccinated by safely and completely,” Khan said. “It’s a big area of ​​interest.”

AAAAI is also looking to the future, as Khan noted a session on “Preparing for the Next Pandemic: From Mechanisms to Vaccines,” which will highlight vaccine development, lessons learned, immunological strategies and more. .

Of course, there will be sessions on other areas of clinical care across a dozen tracks, including allergens, allergy testing and therapeutics, immune mechanisms, mast cell and eosinophilic disorders, and rhinosinusitis. and eye allergy.

“We have a session on mechanisms and approaches to anaphylaxis, which I think will be interesting,” Khan said. “We have another session called ‘An Ounce of Prevention’ to discuss not only some long-term results, but also more recent studies on how to prevent the development of food allergies.”

Outside of clinical courses, guest lecturer Hannah Valentine, MD, will discuss “The Importance of Diversity in Academia and Team Performance”. Valentine, who was the NIH’s first director for the diversity of the scientific workforce before retiring, will explore strategies for achieving an inclusive culture of excellence.

“It’s a very important topic in anything related to health care,” Khan said.

Other professional questions will be the subject of tracks dedicated to practices in allergy practices, research principles and training and career development. Additionally, networking events and trade shows will be available to foster future opportunities.

Qualified medical students and residents in internal medicine and pediatrics will also attend the meeting through the AAAAI’s Project Chrysalis, which allows these aspiring physicians to attend free of charge.

Attendees are paired with an allergy specialist during the event and learn about the pathogenesis and treatment of allergic and immunological disorders as well as cutting-edge research, in addition to career options in academia, private practice and industry.

“This is another successful ongoing project to improve recruitment in our specialty,” Khan said.

Priorities for his tenure

Beyond the conference, Khan said he wanted to tackle the issue of prior authorization for drugs such as biologics as the first of three priorities during his term as president.

“It continues to be a heavy burden not only for patients, but also for staff, practices and physicians,” he said. “Surveys have shown that it does contribute to burnout. So we’re looking at the things we can do to try to fix it from a specialist perspective.

Khan plans to develop a task force to examine the issue and include the issue in AAAAI’s virtual outreach to Congress.

“Patients with congenital diseases need these potentially life-saving therapies, and every year you have to prove that they still have this disease that is not going to go away on its own,” he said. “This is an area of ​​huge frustrations and delays in care that have a real impact on our patients.”

Next, Khan wants to launch a national program that would expose internal medicine and pediatric residents to the specialty to get them excited about potential careers in allergy and immunology and to let them know what allergists and immunologists do. Diversity would be another objective of the program.

“The curriculum we have in place in Texas covers the full range of different allergy and immunology topics,” Khan said. “We have received many positive comments and we hope to roll out a very similar program in different parts of the country. »

Third, Khan said he wanted to create a drug allergy research grant that would help young researchers get their careers off to a good start, as funding in these areas is somewhat limited.

“The hottest topic is penicillin allergy, and that’s because it’s the most common antibiotic people think they’re allergic to,” he said, adding that 90-95% of people who report a penicillin allergy can tolerate penicillin. .

“Wearing this label has many adverse health effects. If it is a fake label, it should be removed,” he said. “But the grant won’t necessarily be specifically for penicillin allergy.”

Additional AAAAI initiatives

AAAAI has also been busy outside of the meeting, Khan said, as he launched his third journal this month. The Journal of Allergy and Clinical Immunology: Global is the first open access gold publication in the organization’s portfolio, including submissions from Africa, Asia, Australia, Europe, and North and South America.

“We’re thrilled the inaugural issue is out,” Khan said.

Khan also cited the recent and extensive work of the AAAAI’s Vaccine and Medication Monitoring System in Pregnancy (VAMPSS).

“The program was started because expectant mothers were concerned about the impact asthma medication would have on them during their pregnancy, which could have obviously dangerous consequences for both mother and baby,” said Khan.

VAMPSS invites pregnant women to participate in interviews and provide birth outcome data, which Kn said is helpful in learning more about the safety of different drugs and vaccines, including COVID-19 vaccines. .

“We are seeing many tragic losses of pregnant mothers and babies who have died from COVID-19 due to vaccine hesitancy,” he said. “So I think there’s a lot of important work here.”

AAAAI has also joined the American Medical Association’s Scope of Practice Partnership, which aims to prevent specialist scope expansion and ensure patient safety. AAAAI is also including its scope of practice concerns in its virtual outreach to Congress.

“Another thing is serving patients in underserved communities,” Khan continued, as the AAAAI plans meetings between its leaders and patient advocacy organizations.

“We will focus on how we can work effectively to meet the needs of our allergy and immunological patients in these underserved communities,” he said. “Many of us in the academy want to help our members help their patients.”

]]>
The studies included in the list do not question the safety of the COVID-19 vaccine https://parentsofallergicchildren.org/the-studies-included-in-the-list-do-not-question-the-safety-of-the-covid-19-vaccine/ Thu, 17 Feb 2022 22:45:49 +0000 https://parentsofallergicchildren.org/the-studies-included-in-the-list-do-not-question-the-safety-of-the-covid-19-vaccine/ An Australian blog touting “medical freedom” has published a misleading list about the safety of the COVID-19 vaccine. January 20 headline listing reads, “1,000 Peer-Reviewed Studies Questioning COVID-19 Vaccine Safety.” The list was shared on Facebook and flagged as part of Facebook’s efforts to combat fake news and misinformation on its News Feed. (Learn more […]]]>

An Australian blog touting “medical freedom” has published a misleading list about the safety of the COVID-19 vaccine.

January 20 headline listing reads, “1,000 Peer-Reviewed Studies Questioning COVID-19 Vaccine Safety.”

The list was shared on Facebook and flagged as part of Facebook’s efforts to combat fake news and misinformation on its News Feed. (Learn more about our partnership with facebook.)

It was posted on Informed Choice Australia, which describes itself as “an information portal to help you make the right choice”, and says people have the right “to refuse any treatment that has not completed all required clinical trials, including long-term studies.”

Far from “challenging the safety of the COVID-19 vaccine”, as the claim puts it, many of the studies included in this catalog clearly indicate that the benefits of vaccination against COVID-19 outweigh the low risk of infection. side effects, which are rare. The studies collect, interpret and evaluate data on the adverse effects of COVID-19 vaccines, according to the process with Scientific Research.

The list is grouped by categories of adverse effects, with myocarditis – inflammation of the heart muscle – at the top of the list and 226 related studies cited for this category. The risk of myocarditis from COVID-19 vaccines is low and symptoms are normally mild. In comparison, contracting COVID-19 is “a strong and significant risk factor for myocarditis”, especially in children under 16, According to the CDC.

The very first study on the list, which examined four patients with myocarditis after COVID-19 vaccination, states: “The authors do not seek to thwart vaccination efforts, but rather to prepare patients and providers for a rare adverse event but potential.

Of the top 10 studies listed, almost all included similar language. One of the studies put it like this: “Cases tend to be mild, generally do not require specific interventions, and the potential vaccine risks are outweighed by the well-defined risks of COVID-19 infection.”

For other categories of adverse effects, the list again indicated studies that did not question the safety of COVID-19 vaccines:

  • For cerebral vein thrombosis, a blood clot in the brain, one of the cited studies says the frequency of this reaction after COVID-19 vaccination is “significantly lower” than in patients hospitalized with COVID-19.

  • For anaphylaxis, a allergic reaction which causes narrowing of the airways and blocks breathing, one of the studies stated: “The risk of anaphylaxis to mRNA vaccines is present but extremely low and is outweighed by the benefits of the vaccine.”

The blog says it includes 1,000 studies, but some studies appear more than once, under different adverse effect categories. For example, one study appears in both the anaphylaxis and allergic reaction categories, and several studies appear in the myocarditis and pericarditis subcategories.

One listed adverse reaction, called Sweet’s syndrome – a painful skin rash – cites a single study in a single person.

Our decision

A list posted on a blog has a title that says, “1,000 Peer-Reviewed Studies Questioning COVID-19 Vaccine Safety.”

Many of the studies included in the list clearly indicate that the benefits of the COVID-19 vaccination far outweigh the low risk of side effects, which are rare.

The list says it includes 1,000 studies, but some studies appear on the list more than once, under different categories of adverse effects.

We rate this claim as false.

]]>
NeedyMeds Hosts Webinar Series | News https://parentsofallergicchildren.org/needymeds-hosts-webinar-series-news/ Tue, 15 Feb 2022 17:25:00 +0000 https://parentsofallergicchildren.org/needymeds-hosts-webinar-series-news/ Needy Meds, the Gloucester-based health resource for cost-effective medicines, services and support, is running webinars until March. Registration for the free webinars is available at https://register.gotowebinar.com/register/8798249584197102091. NeedyMeds is located at 50 Whittemore St, Gloucester. More information is available by emailing info@needymeds.org. To reach his hotline, call 800-503-6897. February 16, 1 p.m., Becoming an autonomous patient […]]]>

Needy Meds, the Gloucester-based health resource for cost-effective medicines, services and support, is running webinars until March.

Registration for the free webinars is available at https://register.gotowebinar.com/register/8798249584197102091.

NeedyMeds is located at 50 Whittemore St, Gloucester. More information is available by emailing info@needymeds.org. To reach his hotline, call 800-503-6897.

February 16, 1 p.m., Becoming an autonomous patient — With Andrea Baer, ​​Executive Director of Mended Hearts, on how being part of your own healthcare team can improve your health.

February 17, 1 p.m., Caregivers with cancer: rights and resources — Cancer Triage features information on caregiver rights at work, how to replace lost wages while acting as a caregiver, and more.

February 17, 4 p.m., Vaccines and COVID 19: the long term — The Allergy & Asthma Network reviews the latest information on vaccines and the long-term effects of the COVID-19 virus.

February 22, 1 p.m., Rx Outreach: Making Medication Affordable — Learn how to access medications at affordable prices with Rx Outreach, the nation’s largest non-profit online pharmacy.

February 24, 4 p.m., Assistance with health costs – Carla Dellaporta, Director of User Engagement, presents a half-hour highlight of NeedyMeds’ most popular health savings resources.

February 244 p.m.., Single or multiple allergen approach — Allergy & Asthma Network is an in-depth study of sublingual immunotherapy and allergy treatment approaches.

February 25, 1:30 p.m., All About Patient Assistance Programs — 15-minute webinar with PAP Research Manager Kim Anderson on how programs can save you money on medication.

February 28, 12:30 p.m., RemediChain: Drug Recovery — a platform that allows you to donate unused medicines to patients in need.

March 1, 4 p.m., save on pet meds — A 10-minute webinar explains how to use the NeedyMeds medication discount card to save on your pet medications.

March 2, 4 p.m., Saving lives through lung cancer screening — Introducing the American Lung Cancer Screening Initiative to find out if you are eligible for screening and the screening locations near you.

March 4, 12:30 p.m., Assistance with health costs — Carla Dellaporta, Director of User Engagement, highlighted for half an hour the most popular health savings resources offered by NeedyMeds.

March 7, 4 p.m., Seven Secrets to Saving on Medicines — 25-minute webinar with NeedyMeds founder Dr. Sagall.

March Noon, Help Customers Deal With Healthcare Costs — How NeedyMeds healthcare cost solutions can positively impact the lives of patients or clients.

March 10, 1 p.m., Making the Most of Medical Appointments — The Lupus Foundation of America helps you prepare for your next medical appointment.

March 14, 3 p.m., Good Shepherd Pharmacy for the uninsured — Sign up to learn more about Good Shepherd Pharmacy – a membership-based non-profit pharmacy that strives to make medicine accessible and affordable for everyone.

March 16, 1 p.m., Medicaid 101 and other benefits — Triage Cancer covers Medicaid basics and income-based programs including SNAP, SSI, and more.

March 18, noon, Save with the NeedyMeds Drug Discount Card — 20 minute session on how the card saves money on prescriptions, over-the-counter medications, supplies and equipment even if you are insured.

March 30, 3:30 p.m. — MyLinks: free app to manage health records — Learn how to collect, manage and share your health records from one secure location.

]]>
Formoterol Fumarate Market Overview, Product Scope and Demand 2022-2027 – The Grundy Register https://parentsofallergicchildren.org/formoterol-fumarate-market-overview-product-scope-and-demand-2022-2027-the-grundy-register/ Mon, 07 Feb 2022 08:46:48 +0000 https://parentsofallergicchildren.org/formoterol-fumarate-market-overview-product-scope-and-demand-2022-2027-the-grundy-register/ The research reportFormoterol Fumarate Marketincludes qualitative and quantitative insights into the major drivers, restraints, opportunities, and challenges impacting the growth of the global market. The analysis contains detailed statistical data on the market of the main companies, as well as revenue forecasts. The Formoterol Fumarate market study also includes insights into the sales growth of […]]]>

The research reportFormoterol Fumarate Marketincludes qualitative and quantitative insights into the major drivers, restraints, opportunities, and challenges impacting the growth of the global market. The analysis contains detailed statistical data on the market of the main companies, as well as revenue forecasts. The Formoterol Fumarate market study also includes insights into the sales growth of numerous regional and country markets, along with the competitive landscape and company specific analysis for the forecast period. The market report examines the future growth factors along with the current state of the market share, penetration of various types, technologies, applications and geographies till 2027.

In accordance with The formoterol fumarate market is expected to grow at a CAGR of 7.6% over a forecast period (2022-2027).

Sample report:

https://www.marketintelligencedata.com/reports/1586796/global-formoterol-fumarate-sales-market-report-2021/inquiry?Mode=Vaishnavi

The top players analyzed in the report are:

Hovione, INKE, Beaukev, Cipla, Fermion, Aarti Industries, Nilkanth Organics, BEVESPI, Mylan, GNH, Merck Sharp?Dohme Corp, Shreeji Pharma International,

Formoterol fumarate Market segmentation, by type:

Powder

Capsule

Formoterol fumarate Market segmentation, by application:

Asthma

Allergic rhinitis

Others

Regional analysis:

The global formoterol fumarate market is further categorized by region as follows:

North America (United States, Canada, Mexico)

Europe (Great Britain, France, Germany, Spain, Italy, Central and Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia-Pacific)

Latin America (Brazil, rest of LA)

Middle East and Africa (Turkey, GCC, Rest of Middle East)

Report link:

https://www.marketintelligencedata.com/reports/1586796/global-formoterol-fumarate-sales-market-report-2021?Mode=Vaishnavi

Table of Content Formoterol Fumarate Market:

Chapter 1: Formoterol Fumarate Market Overview

Chapter 2: Global Market Status and Forecast by Regions and Types

Chapter 3: Company Profiles, Recent Developments and Investments

Chapter 4: Market competition status by major manufacturers

Chapter 5: Key Manufacturers Overview and Market Data

Chapter 6: Upstream and downstream market analysis

Chapter 7: Cost and gross margin analysis

Chapter 8: Marketing state analysis

Chapter 9: Conclusion of the market report

Chapter 10: Research methodology and reference.

Formoterol fumarate Market Highlights:

– To define, describe and forecast the Formoterol Fumarate product market by type, application, end-user, and region.

– Run the company’s external environment and PEST analysis.

– Develop plans for the organization to deal with the effects of COVID-19.

– To provide analysis of market dynamics, such as market driving forces and market growth restraints.

– Provide market entry strategy study for new or existing businesses including market segment definition, customer analysis, distribution model, messaging and product positioning and analysis of the pricing strategy.

– Track global market trends and study the impact of the COVID-19 outbreak on major global domains.

– Analyze participants’ market opportunities and give industry leaders insight into the competitive landscape.

Personalization:

The Global Formoterol Fumarate Market report can be modified to meet your specific business needs. Because we understand what our clients want, we provide 25% customization for any of our market intelligence data reports at no additional cost to all of our clients.

About Us:

Market Intelligence Data is a global leader in the research industry, providing its clients with contextual and data-driven research services. The organization helps clients create business plans and achieve long-term success in their respective markets. The industry provides consulting services, market intelligence data research studies, and custom research reports.

Contact us:

Irfan Tamboli (Head of Sales) – MARKET INFORMATION DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com

]]>
COVID-19, Qualitative Analysis and 2026 Competitive Industry Scenario https://parentsofallergicchildren.org/covid-19-qualitative-analysis-and-2026-competitive-industry-scenario/ Sat, 05 Feb 2022 06:58:37 +0000 https://parentsofallergicchildren.org/covid-19-qualitative-analysis-and-2026-competitive-industry-scenario/ The report provides details about this industry in terms of specific assessment and in-depth assessment of this company. According to the report, the canine atopic dermatitis treatment market is appropriately segmented into segments. An overview of the industry with respect to market size in terms of earnings and volume, […]]]>




The report provides details about this industry in terms of specific assessment and in-depth assessment of this company. According to the report, the canine atopic dermatitis treatment market is appropriately segmented into segments. An overview of the industry with respect to market size in terms of earnings and volume, along with the current Canine Atopic Dermatitis Treatment market scenario is inculcated in the report.

Global Canine Atopic Dermatitis Treatment Market Research Report 2021-2026 is a historical overview and in-depth study on the current and future market of the Canine Atopic Dermatitis Treatment industry. The report represents a basic overview of the Canine Atopic Dermatitis Treatment market share, status, and competitor segment with a basic introduction of major vendors, top regions, product types, and end industries. This report provides a historical overview of the Canine Atopic Dermatitis Treatment market trends, growth, revenue, capacity, cost structure, and key driver analysis.

Request a sample copy of this report @ https://www.getnewsalert.com/request-sample/14262

The study presents a brief report on the topographical spectrum of this vertical as well as the companies that have gained a prominent position in the market.

Report objectives:

  • Examination of the global canine atopic dermatitis treatment market size by value and size.
  • To accurately calculate market segments, consumption and other dynamic factors of different market units.
  • Determination of key market dynamics.
  • Highlight key market trends in terms of manufacturing, revenue, and sales.
  • To summarize the major players in the global Canine Atopic Dermatitis Treatment industry and show how they compete in the industry.
  • Study of industry procedures and costs, product pricing and various associated developments.
  • To present the performance of different regions and countries in the global Canine Atopic Dermatitis Treatment Market.

An Overview of the Canine Atopic Dermatitis Treatment Market Scope:

  • An overview of the competitive landscape
  • An in-depth analysis of the regional scope
  • An overview of market segmentation

Synopsis of the Competitive Landscape:

  • The Canine Atopic Dermatitis Treatment Market report consists of a brief analysis of the competitive terrain of this industry.
  • The report specifies an analysis of the competitive scope of the field. According to the report, the competitive scope of the canine atopic dermatitis treatment market extends to companies such as Zoetis, Virbac, Toray Industries, Novartis, AB Science, Boehringer Ingelheim, and Elanco Animal Health.
  • Data relating to the industry participant’s current market share, production sites, area served, etc. are included in the report.
  • Company profile information along with data is about their profit margins and models.

Regional Scope Information:

  • The report broadly divides the regional spectrum of this industry. According to the report, the canine atopic dermatitis treatment market has formed its position covering the regions of United States, China, Europe, Japan, Southeast Asia and India. .
  • Details regarding the industry share of these regions are mentioned in the report. In addition, information on growth opportunities for players based in these regions has been specified.
  • The expected growth rate to be recorded by each geography during the forecast period is specified in the report.

A brief of market segmentation:

  • The Canine Atopic Dermatitis Treatment market report presents the segmentation of this vertical with the right precision.
  • The product scope of Canine Atopic Dermatitis Treatment market is segmented into oral, topical and injectable products while the application landscape of Canine Atopic Dermatitis Treatment market is segmented into Hospital, Clinic and Other.
  • Information regarding the industry share accumulated by each product segment, as well as the market value of the industry is provided in the report.
  • Details regarding the production growth are also inculcated in the report.
  • Details regarding the market share with respect to the application spectrum acquired by each application division are defined in the report.
  • The product consumption data of each application as well as the growth rate of each application segment is likely to be recorded over the forecasted period.


The report answers key questions

  • What are the important trends and dynamics?
  • Where will development take place most in the long term?
  • What regulations will impact the industry
  • What does the competitive landscape look like?
  • What are the upcoming openings?

Customization request on this report @ https://www.getnewsalert.com/request-for-customization/14262





]]>
Types, side effects and more https://parentsofallergicchildren.org/types-side-effects-and-more/ Fri, 04 Feb 2022 21:35:24 +0000 https://parentsofallergicchildren.org/types-side-effects-and-more/ Meningitis is an infection that causes swelling of the membranes (brain) that protect your brain and spinal cord. The infection ranges from mild to life-threatening and can lead to serious long-term health effects, including hearing loss and nerve damage. There are several types of meningitis. Viral is the most common and often solves alone. Bacterial […]]]>

Meningitis is an infection that causes swelling of the membranes (brain) that protect your brain and spinal cord. The infection ranges from mild to life-threatening and can lead to serious long-term health effects, including hearing loss and nerve damage.

There are several types of meningitis. Viral is the most common and often solves alone. Bacterial meningitis is the most dangerous. It requires immediate hospitalization and a course of intravenous (IV) antibiotics for weeks.

It is important to seek treatment immediately if you suspect any form of meningitis to reduce the risk of serious health problems, sepsis, and even death.

We will see what types of antibiotics are used to treat bacterial meningitis, how this treatment works and what side effects can occur.

Anyone with bacterial meningitis should receive intravenous antibiotics in the hospital. Antibiotics treat many different types bacterial infections. These drugs kill bacteria or prevent them from growing in your body.

According to the CDC, key symptoms bacterial meningitis in adults include:

In infants and babies, other symptoms may occur:

  • not fed enough
  • a bulging fontanel (“weak spot” on a baby’s head)
  • irregular or slow reflexes

Your doctor may start preventive antibiotic therapy while waiting for confirmation of the type of infection you have. Several different tests can be used to diagnose bacterial meningitis.

These include:

A lumbar puncture is considered one of the best ways to identify the type of bacteria causing your meningitis infection. This test takes a sample of your cerebrospinal fluid (CSF).

There are many types of bacteria that cause meningitis. Treatment should be tailored to the specific cause of your illness, your age, and other health factors.

Even delaying antibiotic treatment for bacterial meningitis for a few hours can increase the probability of mortality.

Antibiotics treat bacterial meningitis in adults and children. People with known or suspected exposure to bacterial meningitis may also take antibiotics to prevent developing the infection.

Doctors may change your treatment plan based on new information they gather about your infection.

Antibiotics for adults

Although there is overlap between the antibiotics used to treat children and adults, some are only prescribed for adult use. This is because antibiotics can be hard on your body while trying to resolve a serious infection.

If you are 18 or older, the first treatment for bacterial meningitis is ceftriaxone or cefotaxime.

Other antibiotics used after the first stage include:

  • ampicillin
  • penicillin G
  • vancomycin
  • meropenem
  • aztreonam
  • rifampin
  • ciprofloxacin

Your doctor may adjust the type of antibiotic given if you:

Antibiotic treatment for bacterial meningitis usually lasts longer or shorter, depending on the type of bacteria causing your infection.

Your antibiotic treatment may also be different if you have nosocomial meningitis. It may occur rarely as a complication of neurosurgery or implantation of a medical device such as a cerebrospinal fluid shunt or deep brain stimulation equipment.

Antibiotics for children

Infants and children are particularly at risk of bacterial meningitis. Their immune system is less developed and more vulnerable to infections.

The type of treatment they receive depends on their age and usually lasts between 1 and 3 weeks.

Newborns less than 2 months old can receive:

  • cefotaxime
  • benzylpenicillin

A child over 2 months old can receive:

  • cefotaxime
  • ceftriaxone
  • vancomycin

Antibiotics for Bacterial Meningitis Exposure

Bacterial meningitis spreads through bodily fluids, including saliva. It can be transmitted if someone near you is coughing.

You may need to take a preventive course of antibiotics in case of exposure. Talk to your doctor if you think you have a suspected or confirmed exposure. They will order tests and work with you to come up with a plan.

Bacterial meningitis is always a medical emergency. You will need to be in the hospital during the treatment.

Your doctor will want to determine the type of infection you have, but may start IV antibiotic treatment while waiting for test results.

An IV is an infusion of fluid or medicine given through a tube or needle into your body. An IV will often go into the crook of your arm or the back of your hand. A secure “port” and tape hold the IV in place.

In addition to antibiotics, you may also receive the following intravenously during your treatment for bacterial meningitis:

  • a steroid to relieve brain swelling
  • fluids to keep you hydrated
  • oxygen, if you have trouble breathing

During your stay in the hospital, the medical team will carefully monitor your condition. They can regularly take your temperature and measure other vital signs. Depending on your symptoms and the effectiveness of antibiotics, you may be hospitalized for a few days or longer.

There are side effects you may experience when taking antibiotics for bacterial meningitis. Some can be quite mild, while others can be very unpleasant.

These may include:

The side effects of antibiotics may depend on your body’s response and the type of medication given. Talk to your doctor about any medication side effects you are experiencing. You may need to change your diet.

In rare cases, people have a severe allergic reaction to an antibiotic. If you have trouble breathing or swelling in your throat, it could be a sign of anaphylaxis, a life-threatening allergic reaction. Get emergency medical help right away.

Recovery from bacterial meningitis once you’ve left the hospital often takes time. Do not overwork yourself and get enough rest. Talk to your doctor about any symptoms you’re experiencing and keep in touch with them to find out how your recovery is going.

On 1 in 5 survivors of meningitis have a lasting health complication.

These include:

  • hearing loss
  • brain damage
  • nervous system damage
  • loss of a limb

This risk of long-term complications increases if bacterial meningitis is left untreated or if treatment is delayed.

There are vaccines to prevent bacterial meningitis, but not viral meningitis. Vaccines against bacterial meningitis have played a key role in reducing the rate and severity of the spread of the infection around the world.

Vaccines are not 100% effective, but can provide substantial protection. In the United States, meningitis vaccines are part of routine immunization for children and adolescents. The main vaccines are MenB and MenACWYthat work against common strains of the disease.

Here is a list of available vaccines and who should get them:

Another important thing you can do to prevent meningitis is to wash your hands regularly. This includes always washing your hands after:

  • use the bathroom
  • changing diapers or encountering feces (like pets)
  • when preparing food

Bacterial meningitis is a serious infection that requires hospitalization and treatment with antibiotics. Delaying treatment can increase the risk of dying or having serious long-term health complications.

You will receive IV antibiotics and other medications and fluids to reduce your symptoms. The treatment can last one to several weeks.

Contact your doctor immediately if you suspect exposure or infection to bacterial meningitis. Keep up to date with your or your child’s vaccination schedule to better protect yourself against the disease.

]]>